肝硬変および重症急性肝不全患者における肝移植：適応と転帰

基本情報

NCT ID

NCT04613921

ステータス

募集中

試験のフェーズ

-

試験タイプ

観察

目標被験者数

3,000

治験依頼者名

European Foundation for Study of Chronic Liver Failure

概要

Management of ACLF is mainly supportive. The poor outcomes lead physicians to consider liver transplantation as an option, even if controversial. In sicker recipients, LT results in immediate survival, but poor medium-term survival rates in some studies. The scarcity of deceased donors obliges to maximize LT success. Alternative strategies, as living-donor LT, should be explored. LDLT has impressive results in Eastern centers, but it is restrained in Western countries, due to potential life-threatening complications in the donor.

対象疾患

介入

依頼者（Sponsor）

実施施設 (5)